IBDEI116 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16571,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,16571,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,16571,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,16572,0)
 ;;=D05.82^^88^879^35
 ;;^UTILITY(U,$J,358.3,16572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16572,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,16572,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,16572,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,16573,0)
 ;;=D05.81^^88^879^37
 ;;^UTILITY(U,$J,358.3,16573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16573,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,16573,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,16573,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,16574,0)
 ;;=D05.80^^88^879^39
 ;;^UTILITY(U,$J,358.3,16574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16574,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,16574,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,16574,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,16575,0)
 ;;=D56.8^^88^879^191
 ;;^UTILITY(U,$J,358.3,16575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16575,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,16575,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,16575,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,16576,0)
 ;;=C82.89^^88^879^77
 ;;^UTILITY(U,$J,358.3,16576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16576,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,16576,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,16576,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,16577,0)
 ;;=D51.8^^88^879^198
 ;;^UTILITY(U,$J,358.3,16577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16577,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,16577,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,16577,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,16578,0)
 ;;=I80.9^^88^879^183
 ;;^UTILITY(U,$J,358.3,16578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16578,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,16578,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,16578,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,16579,0)
 ;;=D45.^^88^879^184
 ;;^UTILITY(U,$J,358.3,16579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16579,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,16579,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,16579,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,16580,0)
 ;;=C77.3^^88^879^113
 ;;^UTILITY(U,$J,358.3,16580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16580,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,16580,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,16580,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,16581,0)
 ;;=C77.2^^88^879^129
 ;;^UTILITY(U,$J,358.3,16581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16581,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,16581,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,16581,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,16582,0)
 ;;=C77.1^^88^879^130
 ;;^UTILITY(U,$J,358.3,16582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16582,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,16582,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,16582,2)
 ;;=^267315
